PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Wednesday reported a loss of $30.8 million in its second quarter.
The Pasadena, California-based company said it had a loss of 41 cents per share.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $43.6 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $20.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
